
Nimbus Therapeutics Secures $210M in Funding for Tech-Enabled Medicines
Biotech company Nimbus Therapeutics has raised $210 million in private financing, including investments from GV (formerly Google Ventures) and returning investors such as SR One, Atlas Venture, and Gates Frontier. This comes after the company sold an experimental pill to Takeda Pharmaceutical earlier this year in a deal that could be worth up to $6 billion. Nimbus has not yet opened a lab, commercialized a drug, or gone public with an IPO.
